Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location
Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following...
Gespeichert in:
| Veröffentlicht in: | Annals of the Academy of Medicine, Singapore Singapore, 2023-07, Vol.52 (7), p.378-379 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 379 |
|---|---|
| container_issue | 7 |
| container_start_page | 378 |
| container_title | Annals of the Academy of Medicine, Singapore |
| container_volume | 52 |
| creator | Soe, Ni Ni Kathirvel, Rajeswari Ong, Kai Zhi Saravanaa, Raajalakshmi Madurai Chonkar, Sonali Prashant Mathur, Manisha |
| description | Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following surgery or infection, smoking, and in vitro fertilisation. The fallopian tube is the most common location of ectopic implantation, accounting for more than 90% of cases. |
| doi_str_mv | 10.47102/annals-acadmedsg.202336 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3070841125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3070841125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-be30f4b4408af23e1b28d3b298abeac0b6bb89260b9468e8532716e857b78ec33</originalsourceid><addsrcrecordid>eNpNkE1PwzAMhiMEYmPwF1COXDrcJEvTI5r4kiZxAK5USepuhTYpTSrYv6diY-JkWX5e23oIoSnMRZYCu9bO6SYk2uqyxTKs5wwY5_KITFmesUSAlMdkChxEIiSwCTkL4R1AZMDkKZlwlYNYgJiSt-dtiNjWlrYYNz72-K0j0trRuEHaaqfX2KKL1FcUbfTdSHY9rp12dku1K_91IzK4D-e_HG281bH27pycVOOjeLGvM_J6d_uyfEhWT_ePy5tVYnkKMTHIoRJGCFC6YhxTw1TJDcuVNqgtGGmMypkEkwupUC04y1I51sxkCi3nM3K129v1_nPAEIu2DhabRjv0Qyg4ZKBEmrLFiKodansfQo9V0fV1q_ttkULxa7fY2S0Odoud3TF6ub8ymHFwCP7p5D-cdXxk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3070841125</pqid></control><display><type>article</type><title>Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Soe, Ni Ni ; Kathirvel, Rajeswari ; Ong, Kai Zhi ; Saravanaa, Raajalakshmi Madurai ; Chonkar, Sonali Prashant ; Mathur, Manisha</creator><creatorcontrib>Soe, Ni Ni ; Kathirvel, Rajeswari ; Ong, Kai Zhi ; Saravanaa, Raajalakshmi Madurai ; Chonkar, Sonali Prashant ; Mathur, Manisha</creatorcontrib><description>Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following surgery or infection, smoking, and in vitro fertilisation. The fallopian tube is the most common location of ectopic implantation, accounting for more than 90% of cases.</description><identifier>ISSN: 0304-4602</identifier><identifier>ISSN: 2972-4066</identifier><identifier>EISSN: 2972-4066</identifier><identifier>EISSN: 0304-4602</identifier><identifier>DOI: 10.47102/annals-acadmedsg.202336</identifier><identifier>PMID: 38904504</identifier><language>eng</language><publisher>Singapore</publisher><subject>Abortifacient Agents, Nonsteroidal - administration & dosage ; Abortifacient Agents, Nonsteroidal - therapeutic use ; Adult ; Female ; Humans ; Methotrexate - administration & dosage ; Methotrexate - therapeutic use ; Pregnancy ; Pregnancy, Ectopic - diagnosis ; Pregnancy, Ectopic - drug therapy</subject><ispartof>Annals of the Academy of Medicine, Singapore, 2023-07, Vol.52 (7), p.378-379</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-be30f4b4408af23e1b28d3b298abeac0b6bb89260b9468e8532716e857b78ec33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38904504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soe, Ni Ni</creatorcontrib><creatorcontrib>Kathirvel, Rajeswari</creatorcontrib><creatorcontrib>Ong, Kai Zhi</creatorcontrib><creatorcontrib>Saravanaa, Raajalakshmi Madurai</creatorcontrib><creatorcontrib>Chonkar, Sonali Prashant</creatorcontrib><creatorcontrib>Mathur, Manisha</creatorcontrib><title>Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location</title><title>Annals of the Academy of Medicine, Singapore</title><addtitle>Ann Acad Med Singap</addtitle><description>Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following surgery or infection, smoking, and in vitro fertilisation. The fallopian tube is the most common location of ectopic implantation, accounting for more than 90% of cases.</description><subject>Abortifacient Agents, Nonsteroidal - administration & dosage</subject><subject>Abortifacient Agents, Nonsteroidal - therapeutic use</subject><subject>Adult</subject><subject>Female</subject><subject>Humans</subject><subject>Methotrexate - administration & dosage</subject><subject>Methotrexate - therapeutic use</subject><subject>Pregnancy</subject><subject>Pregnancy, Ectopic - diagnosis</subject><subject>Pregnancy, Ectopic - drug therapy</subject><issn>0304-4602</issn><issn>2972-4066</issn><issn>2972-4066</issn><issn>0304-4602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1PwzAMhiMEYmPwF1COXDrcJEvTI5r4kiZxAK5USepuhTYpTSrYv6diY-JkWX5e23oIoSnMRZYCu9bO6SYk2uqyxTKs5wwY5_KITFmesUSAlMdkChxEIiSwCTkL4R1AZMDkKZlwlYNYgJiSt-dtiNjWlrYYNz72-K0j0trRuEHaaqfX2KKL1FcUbfTdSHY9rp12dku1K_91IzK4D-e_HG281bH27pycVOOjeLGvM_J6d_uyfEhWT_ePy5tVYnkKMTHIoRJGCFC6YhxTw1TJDcuVNqgtGGmMypkEkwupUC04y1I51sxkCi3nM3K129v1_nPAEIu2DhabRjv0Qyg4ZKBEmrLFiKodansfQo9V0fV1q_ttkULxa7fY2S0Odoud3TF6ub8ymHFwCP7p5D-cdXxk</recordid><startdate>20230728</startdate><enddate>20230728</enddate><creator>Soe, Ni Ni</creator><creator>Kathirvel, Rajeswari</creator><creator>Ong, Kai Zhi</creator><creator>Saravanaa, Raajalakshmi Madurai</creator><creator>Chonkar, Sonali Prashant</creator><creator>Mathur, Manisha</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230728</creationdate><title>Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location</title><author>Soe, Ni Ni ; Kathirvel, Rajeswari ; Ong, Kai Zhi ; Saravanaa, Raajalakshmi Madurai ; Chonkar, Sonali Prashant ; Mathur, Manisha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-be30f4b4408af23e1b28d3b298abeac0b6bb89260b9468e8532716e857b78ec33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abortifacient Agents, Nonsteroidal - administration & dosage</topic><topic>Abortifacient Agents, Nonsteroidal - therapeutic use</topic><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Methotrexate - administration & dosage</topic><topic>Methotrexate - therapeutic use</topic><topic>Pregnancy</topic><topic>Pregnancy, Ectopic - diagnosis</topic><topic>Pregnancy, Ectopic - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soe, Ni Ni</creatorcontrib><creatorcontrib>Kathirvel, Rajeswari</creatorcontrib><creatorcontrib>Ong, Kai Zhi</creatorcontrib><creatorcontrib>Saravanaa, Raajalakshmi Madurai</creatorcontrib><creatorcontrib>Chonkar, Sonali Prashant</creatorcontrib><creatorcontrib>Mathur, Manisha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the Academy of Medicine, Singapore</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soe, Ni Ni</au><au>Kathirvel, Rajeswari</au><au>Ong, Kai Zhi</au><au>Saravanaa, Raajalakshmi Madurai</au><au>Chonkar, Sonali Prashant</au><au>Mathur, Manisha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location</atitle><jtitle>Annals of the Academy of Medicine, Singapore</jtitle><addtitle>Ann Acad Med Singap</addtitle><date>2023-07-28</date><risdate>2023</risdate><volume>52</volume><issue>7</issue><spage>378</spage><epage>379</epage><pages>378-379</pages><issn>0304-4602</issn><issn>2972-4066</issn><eissn>2972-4066</eissn><eissn>0304-4602</eissn><abstract>Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following surgery or infection, smoking, and in vitro fertilisation. The fallopian tube is the most common location of ectopic implantation, accounting for more than 90% of cases.</abstract><cop>Singapore</cop><pmid>38904504</pmid><doi>10.47102/annals-acadmedsg.202336</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0304-4602 |
| ispartof | Annals of the Academy of Medicine, Singapore, 2023-07, Vol.52 (7), p.378-379 |
| issn | 0304-4602 2972-4066 2972-4066 0304-4602 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3070841125 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Abortifacient Agents, Nonsteroidal - administration & dosage Abortifacient Agents, Nonsteroidal - therapeutic use Adult Female Humans Methotrexate - administration & dosage Methotrexate - therapeutic use Pregnancy Pregnancy, Ectopic - diagnosis Pregnancy, Ectopic - drug therapy |
| title | Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A26%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20methotrexate%20in%20the%20management%20of%20ectopic%20pregnancy%20and%20pregnancy%20of%20unknown%20location&rft.jtitle=Annals%20of%20the%20Academy%20of%20Medicine,%20Singapore&rft.au=Soe,%20Ni%20Ni&rft.date=2023-07-28&rft.volume=52&rft.issue=7&rft.spage=378&rft.epage=379&rft.pages=378-379&rft.issn=0304-4602&rft.eissn=2972-4066&rft_id=info:doi/10.47102/annals-acadmedsg.202336&rft_dat=%3Cproquest_cross%3E3070841125%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3070841125&rft_id=info:pmid/38904504&rfr_iscdi=true |